Satinder manages a portfolio of intellectual properties (IP) comprising Bio-Pharmaceuticals, Medical Devices and research tools. These have been licensed to Bio-Pharma, Medical Device and Research Reagent companies. His IP portfolio has helped launch several New Companies. Notable among these include Agalimmune (oncology), Voyager Therapeutics (gene therapy), Apic Bio (gene therapy), Generation Bio (non viral gene therapy), Acworth pharmaceuticals (oncology), Bacainn Therapeutics (Inflammation) and Fulcrum Therapeutics (Rare disease). He also serves on the Executive Board of M2D2 (Mass Medical Device Development), a Medical Device and Biotech incubator located at UMASS Lowell and UMASS, Worcester. Satinder received his Bachelors from Delhi University (DU), his MS and PhD from Jawaharlal Nehru University (JNU), and his MBA from the Isenberg School of Management, UMASS, Amherst.
4:30 PM–5:30 PM Jun 5, 2018 (US - Eastern)